Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

Go back to Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
(NASDAQ: TRAW) Delayed: 0.84 -0.05 (5.62%)
Previous Close $0.89    52 Week High
Open $0.87    52 Week Low
Day High $0.95    P/E N/A 
Day Low $0.84    EPS
Volume 262,224